what is the most performance mid cap stock between january 3 2023 and june 30 2023

MoonLake Immunotherapeutics (MLTX) had the highest return between January 3, 2023 and June 30, 2023 by a mid-cap US stock, returning 381.1%.

ASSET DATE % RETURN
MoonLake Immunotherapeutics (MLTX)
1/3/2023 - 6/30/2023
381.13%
IONQ (IONQ)
1/3/2023 - 6/30/2023
278.99%
Riot Blockchain (RIOT)
1/3/2023 - 6/30/2023
238.68%
Oscar Health (OSCR)
1/3/2023 - 6/30/2023
222.4%
Arlington Asset Investment (AI)
1/3/2023 - 6/30/2023
218.72%
Joby Aviation (JOBY)
1/3/2023 - 6/30/2023
200%
Dream Finders Homes  (DFH)
1/3/2023 - 6/30/2023
177.85%
Upstart Holdings  (UPST)
1/3/2023 - 6/30/2023
163.7%
SoundHound AI (SOUN)
1/3/2023 - 6/30/2023
160%
Protagonist Therapeutics (PTGX)
1/3/2023 - 6/30/2023
150.64%
SkyWest (SKYW)
1/3/2023 - 6/30/2023
142.53%
Green Brick Partners (GRBK)
1/3/2023 - 6/30/2023
130.8%
Sotera Health (SHC)
1/3/2023 - 6/30/2023
123.22%
BridgeBio Pharma (BBIO)
1/3/2023 - 6/30/2023
121.08%
Archer Aviation (ACHR)
1/3/2023 - 6/30/2023
109.14%
ACV Auctions (ACVA)
1/3/2023 - 6/30/2023
106.58%
TG Therapeutics (TGTX)
1/3/2023 - 6/30/2023
106.23%
Soleno Therapeutics (SLNO)
1/3/2023 - 6/30/2023
105.26%
CleanSpark (CLSK)
1/3/2023 - 6/30/2023
104.29%
Root (ROOT)
1/3/2023 - 6/30/2023
104.11%
ELF Beauty (ELF)
1/3/2023 - 6/30/2023
103.36%
Global-E Online (GLBE)
1/3/2023 - 6/30/2023
92.93%
Wayfair (W)
1/3/2023 - 6/30/2023
91.94%
Cinemark (CNK)
1/3/2023 - 6/30/2023
88.14%
M/I Homes (MHO)
1/3/2023 - 6/30/2023
85.51%
Mid-cap stocks are treated as having a market cap between $2B and $10B.